Mr. Damien McCallion:

I will address this question. We asked a number of laboratory people, including our new laboratory quality assurance co-ordinator in conjunction with the laboratory quality assurance co-ordinator from Northern Ireland, to produce an assessment of the breakdown of the 221 cases by laboratory. We worked with the 221+ patient group on this in the same way as we produced an earlier report on the medical status of the 221 women impacted by the original audit. We committed that we would work with them on anything about them first and agree it with them. We have completed that report but there is some additional information they wish to have included and we are closing this out at present. It should have been done earlier but the pressures on the operational system for the laboratory people who had to do the work over the summer delayed it. We expect it to be done within the next two to four weeks. The data we have are there, as is the report, but the patient group has asked us to include some additional information and we are doing this at present. Once it is agreed with the patient group, we will be happy to issue it.